New hope for painful skin condition: CIT-013 enters phase 2 trial
NCT ID NCT06993233
First seen Nov 20, 2025 · Last updated May 10, 2026 · Updated 17 times
Summary
This study tests whether CIT-013 can reduce disease activity in adults with hidradenitis suppurativa, a painful skin condition. About 96 participants will receive either 50 mg, 100 mg, or a placebo every two weeks for 12 weeks. Researchers will compare symptom improvement and track any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CA-01
RECRUITINGBarrie, Canada
Contact
-
CA-02
RECRUITINGLondon, Canada
Contact
-
CA-03
RECRUITINGWinnipeg, Canada
Contact
-
CA-04
RECRUITINGNewmarket, Canada
Contact
-
CA-05
RECRUITINGCalgary, Canada
Contact
-
DE-01
RECRUITINGBochum, Germany
Contact
-
DE-02
RECRUITINGFrankfurt, Germany
Contact
-
DE-03
NOT_YET_RECRUITINGOldenburg, Germany
Contact
-
DE-04
RECRUITINGDresden, Germany
Contact
-
DE-06
RECRUITINGBad Bentheim, Germany
Contact
-
DE-08
RECRUITINGKiel, Germany
Contact
-
ES-01
NOT_YET_RECRUITINGValencia, Spain
Contact
-
ES-02
NOT_YET_RECRUITINGSantiago de Compostela, Spain
Contact
-
ES-03
NOT_YET_RECRUITINGSeville, Spain
Contact
-
ES-04
NOT_YET_RECRUITINGMadrid, Spain
Contact
-
ES-05
NOT_YET_RECRUITINGBarcelona, Spain
Contact
-
Erasmus UMC
RECRUITINGRotterdam, Netherlands
Contact
-
GB-02
NOT_YET_RECRUITINGCardiff, United Kingdom
Contact
-
GB-04
RECRUITINGLondon, United Kingdom
Contact
-
GB-05
RECRUITINGChester, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PL-01
RECRUITINGRzeszów, Poland
Contact
-
PL-02
NOT_YET_RECRUITINGLodz, Poland
Contact
-
PL-03
RECRUITINGKatowice, Poland
Contact
-
PL-05
RECRUITINGWroclaw, Poland
Contact
Conditions
Explore the condition pages connected to this study.